【ALS】「PM-HDE」: 利用肌萎縮性側索硬化症(ALS)患者的iPS細胞來尋找候選藥物
文章出處
Chosun Biz
原文標題
AI and stem cell advancements drive personalized treatment in South Korea
文章序號
7917
智醫科學－AI醫療技術、應用與市場動態
Copyright ©2025 智醫科學 MEDai.tw All rights reserved.
The content of
this site is intended for healthcare and medical professionals.
